Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.48 |
| ▸ | BCHE | P06276 | 2/20 | 0.44 |
| ▸ | CNR2 | P34972 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 5/20 | 0.43 |
| ▸ | CA1 | P00915 | 5/20 | 0.43 |
| ▸ | CA2 | P00918 | 5/20 | 0.43 |
| ▸ | CA9 | Q16790 | 5/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 2/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | BCL9 | O00512 | 1/20 | 0.39 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1065825 | 1.00 | MGLL (0.48) | MGLLBCHECNR2CA12CA1 | |
| SCHEMBL29342666 | 0.98 | MGLL (0.50) | MGLLBCHECNR2CA12CA1 | |
| SCHEMBL32670270 | 0.98 | MGLL (0.50) | MGLLBCHECNR2CA12CA1 | |
| SCHEMBL1065263 | 0.98 | MGLL (0.50) | MGLLBCHECNR2CA12CA1 | |
| SCHEMBL12529864 | 0.91 | MGLL (0.54) | MGLLCA12CA1CA2CA9 | |
| SCHEMBL30685129 | 0.89 | MGLL (0.60) | MGLLBCHECNR2CA12CA1 | |
| SCHEMBL21069827 | 0.89 | MGLL (0.60) | MGLLBCHECNR2CA12CA1 | |
| SCHEMBL3362427 | 0.88 | MGLL (0.44) | MGLLBCHECNR2CA12CA1 | |
| SCHEMBL27356591 | 0.88 | MGLL (0.62) | MGLLBCHECNR2CA12CA1 | |
| SCHEMBL16107573 | 0.87 | MGLL (0.58) | MGLLCA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8450469-B2 | Synthesis of peptide nucleic acids conjugated with amino acids and their application | PANAGENE INC. (KR) | 2013-05-28 | — | — | US | disclosed |
| US-20110014715-A1 | Synthesis of Peptide Nucleic Acids Conjugated with Amino Acids and Their Application | PANAGENE INC. (KR) | 2011-01-20 | — | — | US | disclosed |
| WO-2009093821-A9 | SYNTHESIS OF PEPTIDE NUCLEIC ACIDS CONJUGATED WITH AMINO ACIDS AND THEIR APPLICATION | 주식회사 파나진 (KR) | 2010-05-27 | — | — | WO | disclosed |
| WO-2009093821-A2 | SYNTHESIS OF PEPTIDE NUCLEIC ACIDS CONJUGATED WITH AMINO ACIDS AND THEIR APPLICATION | PANAGENE INC. (KR) | 2009-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110014715-A1 | Synthesis of Peptide Nucleic Acids Conjugated with Amino Acids and Their Application | CPSF6, RNGTT, DNPEP | MGLL 1954/4885BCHE 3384/4885CNR2 4845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.